Study to Assess the Efficacy and Safety of NEXIUM for Maintenance of Healing of Erosive Esophagitis
Condition:   Erosive Esophagitis Interventions:   Drug: Nexium 20mg;   Drug: Nexium 10mg Sponsors:   AstraZeneca;   IQVIA RDS Inc.;   Calyx;   Labcorp Central Laboratory Services;   Medidata Solutions;   Thermo Fisher Scientific;   CISCRP (Center for Information and Study on Clinical Research Participation);   Quipment Inc.;   Little Journey Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2022 Category: Research Source Type: clinical trials

Bioequivalence Study of Esomeprazole 20 Milligram (mg) Delayed-Release Capsules in Healthy Adult Participants
Condition:   Gastrointestinal Diseases Interventions:   Drug: Esomeprazole 20 mg Delayed-Release Capsules;   Drug: Esomeprazole 20 mg Delayed-Release Capsules (Nexium 24HR) Sponsor:   GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 3, 2022 Category: Research Source Type: clinical trials